Clinical trial
Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose…
NCT00076999 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00076999 |
|---|---|
| Title | Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children |
| Official title | Multiple-dose, Open-label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-dose Ritonavir in HIV-infected Pediatric Patients |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | TPV oral solution, RTV oral solution |
| Enrollment | 115 |
| Start date | Nov 1, 2003 |
| Primary completion | Jun 1, 2010 |
| First posted | Feb 10, 2004 |
| Last update posted | May 12, 2014 |
| Countries | Argentina, Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: